Clinical Management of Cutaneous Adverse Events in Patients on Targeted Anticancer Therapies and Immunotherapies: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
October 2018
in “
Clinical & Translational Oncology
”
cutaneous adverse events papulopustular eruptions xerosis pruritus targeted anticancer therapies immunotherapies dermatological toxicities TKIs EGFR inhibitors immune checkpoint inhibitors skin toxicities skin reactions dry skin itching tyrosine kinase inhibitors epidermal growth factor receptor inhibitors
Studysummary This review outlines dermatological toxicities associated with targeted cancer therapies and immunotherapies, emphasizing the need for collaborative management by oncologists and dermatologists but reports no new clinical findings.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on link.springer.com →